Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure

Eur J Endocrinol. 2006 May;154(5):739-44. doi: 10.1530/eje.1.02135.

Abstract

Background and objective: Mutations in bone morphogenic protein 15 (BMP15) and growth/differentiation factor 9 (GDF9) lead to altered fertility in animal models. In the human, a heterozygous point mutation of BMP15 has been associated with premature ovarian failure (POF).

Subject and methods: We have directly sequenced both genes in a cohort of 203 POF patients presenting with primary or secondary amenorrhea and high FSH levels and in a control population including 54 women with regular menstrual cycles who had at least one child.

Results: We have identified several heterozygous variants. One alteration in GDF9 (S186Y) and one in BMP15 (L148P) may have pathogenic effects as both positions are conserved in vertebrate species, ranging from the chicken to mammals. These variants were absent in the control samples. We also found synonymous and neutral substitutions.

Conclusions: We propose that although mutations in BMP15 and GDF9 are not a major cause of ovarian insufficiency, they may be involved in POF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amenorrhea / genetics
  • Amino Acid Sequence
  • Animals
  • Bone Morphogenetic Protein 15
  • Cohort Studies
  • Conserved Sequence
  • Evolution, Molecular
  • Female
  • Genetic Variation
  • Growth Differentiation Factor 9
  • Heterozygote
  • Humans
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Molecular Sequence Data
  • Mutation
  • Phenotype
  • Primary Ovarian Insufficiency / genetics*
  • Sequence Analysis, DNA

Substances

  • BMP15 protein, human
  • Bone Morphogenetic Protein 15
  • GDF9 protein, human
  • Growth Differentiation Factor 9
  • Intercellular Signaling Peptides and Proteins